Eye cream with peptides can be developed to improve the appearance of fine lines, dryness, puffiness, or dark circles under the eyes. These problems are often discussed together because they affect a small area of the face, but from a scientific point of view they are different endpoints. Evidence of improved hydration does not automatically mean a reduction in pigmentation, and reducing visible puffiness does not prove that wrinkles have been structurally corrected.
The term „peptide” also includes a very broad group of ingredients, not just one standardized type of cosmetic product. Peptides can differ in their amino acid sequence, chemical modifications, concentration, and proposed function. The entire formulation in which they are contained also matters; therefore, two eye creams advertised as peptide products can contain completely different ingredients and have a very different level of scientific validation.
Published studies of products used around the eyes include small studies without a control group, multi-component skincare regimens, randomized or split-face studies, instrumental measurements, and laboratory studies. In some of them, beneficial cosmetic changes were noted. However, since eye products usually contain several active and auxiliary ingredients, many studies do not allow determining which part of the observed effect was specifically due to the presence of the peptide.
The most useful interpretation of studies on eye creams with peptides therefore lies in associating each claim with the formulation being studied, the measured effect, the comparison used, the population studied, and the limitations of the study design.
We explain in the article why evidence regarding the skin around the eyes, eyelashes, and other areas should not be treated interchangeably. Peptides in the eye area.
What effects do the eye products actually claim to have?
Marketing promises must be translated into a measurable result
Eye products are often described using terms such as brightening, reducing puffiness, smoothing, firming, lifting, or moisturizing. Such claims are much easier to scientifically evaluate if they are translated into specific questions that can actually be investigated.
For example, if a product is intended to brighten the area under the eyes, researchers can check whether the visible darkening has decreased compared to the baseline or control area. In the case of a claim regarding puffiness, a standardized measure of its severity or other measurements related to the contour of the eye area can be used. Wrinkles, on the other hand, can be assessed using three-dimensional imaging of the skin surface, clinical scales, or other validated methods. Hydration requires a different type of measurement.
This distinction is important because broad terms such as „a more rested appearance” usually refer to a subjective aesthetic assessment rather than to a specific biological mechanism.
Similarly, the statement that the skin „seems firmer” does not indicate an increase in collagen production. The claim that the cream „reduces bags under the eyes” also needs to be clarified as to what exactly has been measured. Temporary swelling, visible dark circles and structural bags under the eyes do not necessarily constitute the same phenomenon.
Without a clear definition of the effect being studied, one marketing slogan may unknowingly combine several distinct biological and cosmetic processes.
Therefore, a study of an eye product containing peptides can provide valuable evidence for these effects that have actually been evaluated, while at the same time not confirming all the mechanisms attributed to individual components. Cosmetic improvement should not, for example, be described as „counteracting cellular aging” just because one of the components was separately studied in aging-related laboratory models.
The entire formulation of the eye cream is a tested intervention
Creams, gels, and eye serums rarely consist solely of one peptide.
They usually contain moisturizing ingredients, emollients, antioxidants, plant ingredients, caffeine, vitamins, preservatives, and many other formulation elements. The product base itself can improve hydration, change the sensations on the skin, or affect the way light reflects off its surface.
Therefore, the improvement in the appearance of the eye area after using the finished product cannot be automatically attributed to the peptide indicated on the packaging.
In an open-label clinical study, multi-directional eye cream was evaluated in 40 women for 12 weeks; 37 participants completed the study. The formulation combined peptides with vitamin C derivative, caffeine, plant ingredients, and other substances. The researchers noted favorable changes in appearance assessments.
This constitutes useful evidence regarding the entire product under review.
However, since the preparation contained many ingredients and the study design did not include an appropriate comparison that would allow the impact of individual components to be isolated, it cannot be concluded from it that the peptide itself caused the specific change.
A more precise declaration regarding the peptide would require a more precise comparison.
For example, comparing two possibly identical formulations that differ primarily in the presence of a peptide could provide more information about its additional effects. If the products also differ in several ingredients, the differences in action cannot be attributed with certainty to just one of them.
The same principle is relevant when assessing multipeptide serumThe number of peptides in the composition itself does not determine the strength of the evidence or the effectiveness of the finished formulation.
Creams, gels, and serums describe the formulation, not the level of evidence
The physical appearance of the product can influence how it is applied, how it feels on the skin, and how it fits into daily skincare routines.
However, the terms „cream”, „gel” and „serum” do not indicate different levels of scientifically proven effectiveness.
Gel is not automatically more effective for swelling just because it seems lighter or cooler. Similarly, a richer cream consistency does not automatically mean it has a stronger effect on wrinkles.
The cosmetic product itself does not indicate whether its ingredients remain stable, whether they reach the intended site of action, or whether the finished product has been evaluated in a well-controlled clinical study.
Similar caution should be exercised with terms such as „lifting peptide”, „deep eye lift” or „peptidic technology for firming the skin”.
These are not standardized scientific categories.
If a product is described as lifting, one should ask what exactly has been measured. The improvement in perceived firmness is not the same as a physical displacement of the tissues. Similarly, an improvement in the appearance of the bags under the eyes does not necessarily mean the removal or change of the anatomical structure responsible for their contour.
Dark circles and puffiness under the eyes are different problems
Eye shadows can have different bases
Eye shadows describe the appearance, not a specific biological change.
For some people, pigmentation can be important. For others, visible veins, anatomical conditions, shadows created by the contour of the tissues, or a combination of several factors can affect their appearance.
In the classification study involving 65 cases, dark circles of pigmentary, vascular, structural, and mixed nature were identified.
This classification helps to understand why one cosmetic ingredient or one type of measurement does not necessarily solve the problem of dark circles under the eyes for every person.
However, this classification should not be used as a home diagnostic system based solely on the color visible in the mirror.
Lighting, skin tone, the anatomy of the eye area, and other visual factors can all affect the appearance of this area. Therefore, the study is more useful as evidence of the variation in eye shadow shades than as a universal way to choose cosmetics.
When people with dark circles are included in a cosmetic study, it is worth checking how this problem has been defined.
Were the participants classified based on pigmentation, the visibility of blood vessels, or structural characteristics? Did different types of blood vessels appear in one group?
A heterogeneous population may react differently than a carefully selected subgroup, which affects the possibility of generalizing the results.
The discoloration affects the contour, not the pigmentation
Swelling usually describes a more full, swollen or bulging appearance of the eye area.
Its severity can vary, and the visible bag under the eye is not necessarily the same as a temporary swelling associated with fluid accumulation.
The anatomy can also affect the contour of the under-eye area and the shadows that form around it.
In studies classifying dark circles under the eyes, ultrasound was used to distinguish features related, among other things, to swelling and bulging of the fat pads.
This shows why it should not be assumed that every visible eye bag can be removed by a cosmetic product called „anti-swelling”.
The product can improve the photographic or clinical assessment of swelling without showing that a deeper anatomical structure has been removed or moved.
The contour and color can also influence each other in their appearance.
If the contour changes, the shadow located beneath it may become less visible, even if the pigmentation remains unchanged.
Meanwhile, improving skin color does not automatically mean reducing swelling.
Both effects may have cosmetic significance, but from a scientific point of view they should be evaluated separately.
Combined declarations require separate measurements
If an eye product is intended to reduce both dark circles and puffiness at the same time, a well-described study should explain how each of these effects was assessed.
A general assessment of satisfaction does not allow us to determine whether the skin darkening, the swelling, both parameters, or simply the participants considered the skin smoother or better moisturized.
Photographs also require careful interpretation.
Differences in lighting, facial expressions, camera positioning, and head angle can change the visibility of shadows and make the contour under the eyes appear more or less pronounced.
Standardized photography increases comparability, but it still does not allow determining whether the change resulted from a reduction in pigmentation, a change in vascular characteristics, hydration, a change in contour, or another mechanism.
The most reliable formulation therefore describes what was actually observed.
The term „improvement in the appearance of the skin under the eyes” may be appropriate if the overall clinical assessment has improved.
A much more specific statement, such as „reduction in pigment production,” requires evidence that relates directly to pigmentation.
Wrinkles and hydration require a separate interpretation
Moisturizing can reduce the visibility of fine lines without evidence of skin remodeling
The moisturizing formulation can make superficial fine lines less noticeable.
This can be a real and useful cosmetic effect.
However, improving the appearance of the skin surface, which results at least partly from hydration, should not automatically be presented as evidence of the production of new collagen or the lasting remodeling of deeper tissues.
In a 12-week study involving 22 participants, the eye contour formulation containing OS-01 was evaluated for hydration, transdermal water loss, firmness, elasticity, and appearance in photographs. In several measurements, improvements were noted compared to baseline values.
The study provides information about the finished formulation.
At the same time, the small number of participants, the „before and after” type of project, and the multi-component nature of the product limit the ability to attribute the observed changes to any one component.
In particular, these results do not prove on their own that the peptide „reversed the cellular aging of the skin” of the participants.
Various measuring devices also assess different properties.
Transcutaneous water loss, or TEWL, describes the flow of water through the skin outwards under controlled conditions. It is not the same as measuring skin moisture.
Similarly, a device measuring elasticity assesses certain mechanical properties of the skin. It does not directly measure the amount of collagen.
All these results can provide valuable information, but they should be presented as separate measurements, rather than being combined into a broad claim about „skin renewal”.
Imaging the surface of the skin provides more detailed data about wrinkles
Techniques of three-dimensional imaging of the skin surface allow quantitatively assessing roughness characteristics and the geometry of wrinkles, which can be difficult to reliably determine in ordinary photographs.
However, the precision of instrumental measurement does not eliminate the need for an appropriate research design.
The participant's position, facial expressions, the precisely analyzed area, and the measurement conditions should remain as constant as possible.
In two randomized split-face studies involving 42 and 35 women, respectively, several products containing niacinamide and peptides were evaluated using three-dimensional measurements of the area around the eyes.
The individual products and the evaluated parameters did not yield identical results in all studies.
This is important because it shows that even similar formulations should not be treated automatically as equivalent.
The studies compared areas undergoing care with areas not undergoing care, and not with appropriately matched cosmetic bases devoid of selected ingredients.
The results therefore relate to complete products used in these experiments.
They do not allow the influence of the peptide to be isolated from the action of niacinamide, the cosmetic base, and the other ingredients.
The issue of combining these components is discussed in more detail in the material. Peptides and niacinamide.
Biological models and cosmetic effects in humans answer different questions
Some cosmetic studies combine laboratory experiments with clinical studies.
This can be valuable because laboratory models help to investigate the biological plausibility of the proposed mechanism, whereas clinical measurements allow the assessment of the visible or instrumentally measurable effects in humans.
However, these two types of evidence should not be combined into a single application.
Changing the molecular marker in a laboratory model of the skin does not prove that the same change occurred to the same extent in every person who used the product.
In the study of a topical eye cream, biomarkers were evaluated in tissue models, as well as instrumental and clinical results in 33 women. Some instrumental changes occurred earlier than the changes observed in the clinical assessment.
This is an important observation because it shows that the measurement method and the moment of assessment can influence when a given change becomes detectable.
However, this does not mean that an early instrumental signal is automatically equivalent to a visible improvement.
It also does not prove that each component of the finished formulation was responsible for the observed change independently.
Before such results can be presented as evidence regarding a particular peptide, the composition of the product and the experimental comparisons used must allow for such an attribution.
The publication regarding an eye cream containing a peptide is not automatically an investigation into the individual effects of that peptide.
The measurement should correspond to the declared effect
Different measurements answer different questions.
Humidity measurement can provide information about properties related to the water content in the outer layers of the skin, but it does not itself confirm collagen production or lasting wrinkle correction.
TEWL provides information about the loss of water through the skin under certain conditions, but it does not measure all elements of the skin barrier function.
Colorimetry or validated scales of dark circles can assess visible color or the degree of darkening, but none of these measurements alone indicates whether the change is due to pigmentation, vascular features, or another mechanism.
The extent of swelling can quantitatively describe the change in the visible contour, but it does not prove the removal of the anatomical fat pad.
Surface skin imaging can objectively describe the shape of wrinkles or roughness, but without an appropriate control group it is not possible to determine which component of the product was responsible for the change.
Participant questionnaires can provide valuable information about perceived appearance, comfort, or satisfaction, but subjective assessment is not a direct measure of structural tissue remodeling.
These results can complement each other.
However, they should not be treated as synonyms.
This is particularly important when one eye cream is advertised simultaneously as a product for wrinkles, bags, puffiness, dark circles, firmness and hydration.
How are the studies of products used around the eyes evaluated?
Validated scales improve the measurement quality
The validated clinical scale aims to increase the consistency of visual assessment between different observers and subsequent visits.
In the studies, the photographic scale of dark circles was developed and evaluated, and then it was used in an eight-week randomized split-face study involving 58 participants.
The defined evaluation system provides more interpretable information than an imprecise statement that the eye area simply looked „better”.
However, the validation of a measurement tool should not be confused with the confirmation of the effectiveness of each product evaluated using it.
A well validated scale can consistently measure the degree of under-eye shadows, while the clinical study itself may still have limitations regarding randomization, control, sample size, or the ability to attribute the effect to a specific component.
The quality of the measurement and the ability of the research project to demonstrate a causal relationship therefore address two different scientific problems.
Stronger evidence requires both of these elements.
The type of control determines what can be attributed to the product
The type of comparison used has a major impact on what conclusions can be reasonably drawn.
Comparing the area that is not being cared for can help determine whether using the complete product changes the outcome compared to not using the product.
Comparison with a properly matched cosmetic base, however, can provide more information about whether the added active ingredients provide an effect that goes beyond the action of the base formulation itself.
If the goal is to determine the specific contribution of a single peptide to a multi-component product, a component comparison is necessary.
Split-face studies can be particularly useful because the same person has both the researched area and the comparison area, which limits the amount of differences between the participants.
Such studies still require the control of the natural asymmetry of the face, the possibility of transferring the product between the sides, the regularity of application, and the blinding of the evaluators.
The term „split-face study” therefore provides important methodological information, but it does not automatically eliminate all potential sources of error.
Open-label studies provide a different kind of evidence.
They can document the changes observed during the use of the product and generate hypotheses for further research, but both the participants and the researchers know which intervention is being used.
Therefore, expectations, parallel elements of care, natural variability, and regression to the mean can all influence the outcome.
Small pilot studies require proportionate proposals
In a six-week pilot study of an eye cream containing defensins, eight people completed the study. Improvements were noted in subjective and instrumental assessments.
This is preliminary evidence.
A study of this size cannot confirm that a similar scale of effect occurs in a wider population, and the number of participants may be too small to detect less common tolerance issues.
High percentages also require context.
The percentage calculated based on the instrumental result or the clinical scale should not be automatically interpreted as the same percentage of reduction in visible wrinkles.
The absolute values, the initial severity of the problem, variability, and the way the percentage change is calculated are important.
Therefore, percentage results derived from independent cosmetic studies should not be directly compared or used to create rankings without checking what exactly was measured.
Multipurpose care regimens do not allow for isolation of each stage
Studies involving several products create an additional problem with attributing the effect.
In an open-label study of an eye cream containing a retinoid, there was a smaller subgroup of participants who used a peptide-rich cream in the morning as part of their AM/PM skincare regimen.
Because the study was not designed as a pure randomized comparison to isolate the effect of the morning peptide product, it cannot be used to determine the independent contribution of this care component.
Improvements observed in different groups should not be presented as if they automatically constitute a statistically correct direct comparison of interventions.
This is especially important when recommendations regarding individual products are formulated based on studies of entire care regimens.
The study may show that beneficial changes occurred during the use of a specific routine, but it does not prove that each element of the routine was essential or precisely determine how large an impact the product containing the peptides had.
A separate issue is the combination of peptides with retinoids. We discuss them in more detail in the article. Peptides and retinol.
The population and the duration of the study influence the possibility of generalizing the results.
When evaluating the study of eye cream, the characteristics of its participants are important.
It is worth paying attention to age, skin tone, the initial severity of the problems being assessed, previous cosmetic procedures, and exclusion criteria.
The studies conducted in a carefully selected group of healthy volunteers do not have to address questions about people with active eyelid inflammation, eye diseases, or all possible types of dark circles under the eyes.
The duration of the study is also important.
The improvement noted after eight or twelve weeks of regular use indicates what was observed at that point in time.
It does not automatically mean that the effect will persist after discontinuing the product.
Terms such as „long-lasting effect” should therefore be interpreted in relation to the actual time of observation, and not as a synonym for permanence.
In order to more accurately assess the persistence of the effect, further observation would be needed after the end of product use.
Tolerance and limitations of evidence
The tolerance around the eyes should be evaluated for the entire formulation.
The presence of the peptide does not guarantee that the eye cream will not cause irritation.
Tolerance depends on the entire formulation, including the other ingredients, the base, the application site, the frequency of contact with the skin, and the individual characteristics of the user.
The good tolerance observed in one small study does not also mean that every person will tolerate another product containing a similar peptide equally well.
General recommendations for cosmetics used around the eyes emphasize the importance of using them according to their intended purpose and discontinuing their use in the event of irritation.
This is especially important when trying to transfer results regarding general facial care to the area around the eyes.
A product study for the face can provide relevant information if it has actually been evaluated on the skin around the eyes, but good tolerance in other areas of the face does not automatically mean that the product is suitable for the eyelids or the surface of the eye.
The term „tested ophthalmologically” also requires context.
By itself, it does not inform about how many participants were examined, what tests were performed, how long the observation lasted, or what adverse effects were reported.
Therefore, it should not be interpreted as a guarantee that no person will experience irritation or any other reaction.
Cosmetic swelling and eye problems are different issues
Clinical studies regarding stable, cosmetic swelling under the eyes do not cover all possible causes of swelling in this area.
New or increased redness, pain, significant swelling, or visual disturbances are a different situation from the usual cosmetic endpoint of the examination.
Persistent or aggravated symptoms require appropriate professional evaluation instead of further experimentation with cosmetics.
Similarly, a home evaluation of the product does not allow for the recognition of allergies or confirmation that the formulation is suitable for direct contact with the surface of the eye.
The product intended for the skin around the eyes is not automatically intended for insertion into the eye.
Instructions for one product for under the eyes should not be automatically transferred to another formulation or another application site.
The conclusions of the study should be read in conjunction with its methodology.
The authors can conclude that the eye cream under review was effective and well tolerated, but the strength of this conclusion depends on the way the study was conducted.
Short studies without a control group, pilot studies involving eight people, and randomized controlled trials should not be treated as equivalent forms of evidence just because they all yielded favorable results.
The available literature provides useful information about specific cosmetic effects and shows various methods for evaluating products used around the eyes.
However, it does not prove that every eye cream with peptides can affect all the causes of dark circles, puffiness, dryness, or wrinkles.
Future studies could provide stronger evidence through larger and more diverse populations, appropriate control groups, independent replication of results, clearly defined endpoints, and transparent reporting of both beneficial and adverse observations.
Frequently asked questions about peptides eye creams
Does reducing puffiness mean improving dark circles under the eyes?
No. Swelling and darkening of the skin are different effects. A change in contour can affect the shadows that form under the eye without reducing pigmentation or changing the vascular characteristics. Clinical studies indicate various possible factors affecting the appearance of shadows under the eyes, including pigmentary, vascular, structural, and mixed factors. If the study reports improvement in both swelling and shadows, both effects should be evaluated separately.
Can the results of the face cream tests be directly applied to the eye cream?
Not automatically. The formulation, intended application site, and exposure conditions may vary. Some studies of facial products do indeed assess wrinkles around the eyes, making their results relevant to that particular endpoint. However, they still do not confirm the efficacy of another eye cream. A common peptide or similar marketing terms alone are not sufficient to establish product equivalence.
Do all dark circles under the eyes result from excessive pigmentation?
No. Pigmentation is only one of the possible factors. In clinical studies, types of pigmentation have been distinguished: vascular, structural, and mixed. The anatomical contour can create a shadow, the visibility of blood vessels can affect the color, and several factors can occur simultaneously. Therefore, a product described as a concealer does not necessarily affect every type of under-eye shadow in the same way.
Can an eye cream with peptides remove the anatomical bags under the eyes?
The cosmetic studies discussed do not confirm the removal of the anatomical fat pad. The cosmetic product can favorably affect the visible contour, hydration, or assessment of swelling without physically removing or moving deeper tissues. A declaration regarding an anatomical change would require studies directly demonstrating such an effect.
Does better hydration mean that the cream has increased collagen production?
No. Hydration and collagen production are separate effects. Research on eye products can measure hydration, TEWL, firmness, elasticity, or skin appearance without directly measuring newly produced collagen. Better hydration can smooth the surface of the skin and reduce the visibility of fine lines, which in itself can be a useful cosmetic effect. However, it should not be automatically described as tissue repair.
Does the improvement in the appearance of wrinkles prove that the peptide was responsible for it?
Not necessarily. Many eye creams contain several active and auxiliary ingredients. Therefore, a positive result may confirm the effect of the entire formulation, without indicating which component was responsible for the change. A properly matched control base or a component comparison would provide stronger evidence of the additional contribution of the peptide.
Are eye creams better than creams for swelling?
The terms „gel” and „cream” alone do not confirm anti-swelling effects. The consistency may affect the user’s perception, but the sensation of coolness or lightness is not the same as a clinically measured reduction in swelling. To determine the superiority of a particular product form, a direct comparison using appropriate measurements would be necessary.
Can the „before and after” photo confirm a reduction in melanin levels?
No. The photo may document a change in appearance, but it does not allow the individual to determine the biological cause of the color difference. Standardized photography and validated eye shadow shades improve the quality of the assessment, but do not automatically demonstrate a reduction in melanin production. Lighting, facial contour, shadows, and contrast with the surrounding skin can all influence the visible effect.
What does the validated eye shadow scale add to the study?
It provides a defined and previously evaluated way of determining the severity of dark circles under the eyes. It can increase the consistency of measurements between observers and subsequent visits compared to the imprecise statement that the eye area looked „better”. However, a validated measurement tool does not automatically mean that the design of the product study allows the causal relationship to be demonstrated.
Does the immediate effect mean a lasting correction of wrinkles?
No. Immediate change in the appearance of the skin surface or instrumental measurement does not indicate structural remodeling or the durability of the effect. „Immediate” and „long-lasting” are two different scientific statements. Evaluation of durability requires a correspondingly long period of observation, and maintaining the effect after discontinuation of the product is best evaluated even after its discontinuation.
Does a large percentage improvement mean a very noticeable difference?
Not necessarily. The percentages can be calculated based on very different instrumental measurements, clinical scales, and baseline values. The absolute change, the initial severity of the problem, variability, and the clinical or cosmetic significance of the result also matter. Therefore, percentages derived from different studies should not be directly compared without checking the way they were calculated.
Does the AM/PM routine study prove that an early peptide product was necessary?
No. A regimen involving several products requires a proper comparison of the components to determine the independent contribution of each. If participants used several products simultaneously, the study may describe the effects of the entire routine, but it does not prove that each component was necessary or precisely determine the contribution of the peptide product.
Does the absence of irritation in the study mean that anyone can use the cream?
No. Tolerance data refer to a specific formulation, participants, and the length of observation. Small studies may not detect rare reactions, and participants with active dermatological or ocular problems are often excluded from the studies. Another cream containing similar peptides may also contain other preservatives, fragrance substances, solvents, or ingredients that affect tolerance.
Can eye cream with peptides be applied directly to the eye?
Cosmetics intended for the eye area are not automatically intended for contact with the surface of the eye. Studies on the appearance of the skin around the eyes do not confirm the ocular safety or the suitability of the product for application to the eye. The term „eye cream” refers to the area of skin for which the product is intended, and not to its use as an ocular product.
Does the term „tested ophthalmologically” mean no risk?
No. The description itself does not provide information about the number of participants, the duration of the study, the methods used, or the reactions observed. Without this information, it cannot be interpreted as a guarantee of no irritation or other problems. The terminology related to the tests should be evaluated in conjunction with the actual information about the study conducted.
Does one successful study of a peptide cream confirm the effectiveness of a product from another brand?
No. Products can contain different peptide sequences, concentrations, excipients, preservatives, and formulation bases. Even products described in a similar language may behave differently. Evidence can be transferred only if the investigated intervention actually corresponds to the product to which the claim refers. A similar label on the packaging is not sufficient.
How best to evaluate the claim regarding a cream for under-eye wrinkles with peptides?
The most useful question is: did this specific formulation actually lead to a measurable improvement in the specific problem being addressed compared to the corresponding control? The assessment of redness, swelling, hydration and wrinkle imaging answers different questions. The most reliable interpretation thus remains close to the actually measured effect and takes into account the uncertainty regarding the contribution of the individual components.
Summary
Eye creams with peptides constitute a diverse category of cosmetic formulations, rather than a single standardized product type. They can significantly differ in ingredients, type of peptides, concentration, base, and additional components. Therefore, results regarding one formulation should not be automatically transferred to another product simply because both contain peptides.
Scientific literature is much easier to interpret when shadows under the eyes, puffiness, hydration, and wrinkles are treated as separate effects.
The appearance of eyeshadows can be influenced by pigmentation, vascular features, structural shading, or a combination of several factors. Swelling primarily affects the contour and can be of a transient or structural nature. Hydration can reduce the visibility of superficial lines without confirming collagen production, whereas instrumental measurements of wrinkles describe the surface properties of the skin without necessarily indicating the component responsible for the change.
In several studies involving humans using eye products containing peptides, beneficial cosmetic effects have been reported. However, the strength of these evidence is very variable. Some studies are small observational studies of a „before and after” type, others include open, multi-product skincare regimens, and others use controlled or split-face designs. Multi-ingredient formulations often further make it impossible to isolate the peptide component itself.
Therefore, the most reliable conclusions remain strictly related to the specific product, the population being studied, the comparison used, the measurement method, and the duration of the study.
A positive hydration result should remain a hydration-related result. A reduction in visible puffiness should not automatically be considered evidence of a reduction in pigmentation. Improvements in the appearance of wrinkles should not automatically be presented as evidence of increased collagen production, and the overall improvement in the appearance of the eye area should not be extended to claim that all causes of dark circles, bags, and wrinkles have been corrected.
Evidence regarding eye creams with peptides is therefore most useful when interpreted in a precise and transparent manner. Available studies can confirm specific cosmetic observations, but they do not prove that every eye cream containing peptides solves all the problems of this area or that a peptide alone in the composition of the product is responsible for every improvement observed after using a complex formulation.
Disclaimer
The article is purely educational and scientifically informative. It discusses cosmetic formulations, peptide ingredients, the appearance of the eye area, and the interpretation of published studies. It is not intended to diagnose the causes of dark circles under the eyes, swelling, puffiness, wrinkles, or other problems in this area, nor is it medical advice or a recommendation for treatment or care.
Evidence regarding a specific peptide, cream, serum, gel, multi-product routine, or professional treatment should not be automatically interpreted as evidence regarding another product described in similar marketing language. The results of laboratory models, small pilot studies, open-label studies, and controlled clinical trials should remain linked to the conditions in which they were obtained.
Cosmetic swelling and dark circles should also be distinguished from eye-related symptoms. Significant or persistent swelling, pain, pronounced redness, visual disturbances, or severe irritation may require appropriate evaluation by a qualified healthcare professional. Eye cosmetics should be used in accordance with the intended purpose and the instructions for the specific product.
References
- Rajabi-Estarabadi, A., Hartman, C. L., Iglesia, S., Kononov, T., & Zahr, A. S. (2024). Effectiveness and tolerance of multicorrective topical treatment for infraorbital dark circles and puffiness. Journal of Cosmetic Dermatology, 23(2), 486–495. https://doi.org/10.1111/jocd.16122
- Huang, Y. L., Chang, S. L., Ma, L., Lee, M. C., & Hu, S. (2014). Clinical analysis and classification of dark eye circles. International Journal of Dermatology, 53(2), 164–170. https://doi.org/10.1111/j.1365-4632.2012.05701.x
- Zonari, A., Brace, L. E., Li, F., Harder, N. H. O., Harker, C., Jacob, C., Kaufman, J., Chilukuri, S., Oliveira, C. R., Boroni, M., & Carvalho, J. L. (2025). Clinical efficacy of OS-01 peptide formulation in reducing the signs of periorbital skin aging. International Journal of Cosmetic Science, 47(3), 455–465. https://doi.org/10.1111/ics.13042
- Kaczvinsky, J. R., Griffiths, C. E., Schnicker, M. S., & Li, J. (2009). Efficacy of anti-aging products for periorbital wrinkles as measured by 3-D imaging. Journal of Cosmetic Dermatology, 8(3), 228–233. https://doi.org/10.1111/j.1473-2165.2009.00444.x
- D’Arcangelis, A., Goswami Chatterjee, S., Diaz, I., Guehenneux, S., Namkoong, J., & Wu, J. (2025). In vitro, ex vivo, instrumental and clinical evaluation of a topical cream on the signs of periorbital aging. International Journal of Cosmetic Science, 47(1), 18–30. https://doi.org/10.1111/ics.12987
- O’Mahony, M. M., Sladen, C., Crone, M., Banner, E., Newton, V. L., Allen, A., Bell, M., Marlow, I., Acevedo, S. F., & Jiang, L. I. (2021). A validated photonumeric scale for infraorbital dark circles and its application in evaluating the efficacy of a cosmetic treatment product in a split-face randomized clinical trial. International Journal of Cosmetic Science, 43(1), 48–56. https://doi.org/10.1111/ics.12668
- Berens, A. M., & Ghazizadeh, S. (2020). Effect of defensins-containing eye cream on periocular rhytids and skin quality. Journal of Cosmetic Dermatology, 19(8), 2000–2005. https://doi.org/10.1111/jocd.13424
- Kaufman, J., Callender, V., Young, C., Jones, P., Wortzman, M., & Nelson, D. (2022). Efficacy and tolerability of a retinoid eye cream for fine to moderate wrinkles of the periorbital region. Journal of Drugs in Dermatology, 21(9), 932–937. https://doi.org/10.36849/JDD.6815
- U.S. Food and Drug Administration. (n.d.). Eye cosmetic safety. Retrieved September 25, 2026, from https://www.fda.gov/cosmetics/cosmetic-products/eye-cosmetic-safety